KCT0008111已完成未知
ong-term clinical outcome of chronic hepatitis B naive patients treated with entecavir and tenofovir in Korea
Hallym University Medical Center-Dongtan0 个研究点目标入组 2,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 18(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •Patients who were prescribed entecavir as an initial treatment for chronic hepatitis B between January 2011 and January 2014
- •Patients who were prescribed tenofovir as an initial treatment for chronic hepatitis B between December 2012 and December 2015
排除标准
- •Patients who could not be followed up within 1 year after administration of entecavir or tenofovir
- •Patients diagnosed with liver cancer before and within 1 year after administration of entecavir or tenofovir
- •Patients diagnosed with other types of malignancies during the 5 years prior to administration of entecavir or tenofovir
- •Patients co-infected with HCV or HIV
研究者
相似试验
已完成
4 期
Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)Chronic hepatitis BJPRN-UMIN000031832Stanford University Medical Center270
招募中
不适用
Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate PhaseChronic Hepatitis bNCT05661786The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School4,500
进行中（未招募）
不适用
A Comparative Study of Chronic Hepatitis B Subjects Treated with Entecavir PlusTenofovir Combination Therapy vs Entecavir Monotherapy in Adults who are Treatment-Naïve to Nucleosides and Nucleotides: The BE-LOW Study.Revised Protocol 01, incorporating protocol amendment 02 (Version 2.0, Date 22-Jan-07). - The BE-LOW StudyEUCTR2006-000421-62-GRBristol-Myers Squibb International Corporation462
进行中（未招募）
不适用
A Comparative Study of Chronic Hepatitis B Subjects Treated with Entecavir Plus Tenofovir Combination Therapy vs Entecavir Monotherapy in Adults who are Treatment-Naïve to Nucleosides and Nucleotides: The BE-LOW Study - The BE-LOW StudyCHRONIC HEPATITIS B VIRUS,TREATMENT-NAIVMedDRA version: 6.1Level: PTClassification code 10019731EUCTR2006-000421-62-ITBristol-Myers Squibb International Corporation462
进行中（未招募）
1 期
A Comparative Study of Chronic Hepatitis B Subjects Treated with Entecavir PlusTenofovir Combination Therapy vs Entecavir Monotherapy in Adults who are Treatment-Naïve to Nucleosides and Nucleotides: The BE-LOW Study.Revised Protocol 01, incorporating protocol amendment 02 (Version 2.0, Date 22-Jan-07). - The BE-LOW StudyCHRONIC HEPATITIS B VIRUS,TREATMENT-NAIVMedDRA version: 8.1Level: LLTClassification code 10019743Term: Hepatitis B virus (HBV)EUCTR2006-000421-62-FRBristol-Myers Squibb International Corporation462